LISA SANDERS: Open Payments
NPI 1124161849 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,433 in 164 payments from 31 companies in 2025. Trend: 2023 $3,788 · 2024 $3,215 · 2025 $3,433
Food & beverage: $3,384Education: $49
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $581 |
| PFIZER INC. | 24 | $432 |
| Novartis Pharmaceuticals Corporation | 10 | $241 |
| SK Life Science, Inc. | 9 | $231 |
| ARGENX US, INC. | 7 | $225 |
| UCB, Inc. | 13 | $218 |
| Biogen, Inc. | 6 | $162 |
| ACADIA Pharmaceuticals Inc | 5 | $129 |
| EMD Serono, Inc. | 4 | $117 |
| Merz Pharmaceuticals, LLC | 3 | $104 |
Products named: NURTEC ODT, QULIPTA, KESIMPTA, REXULTI, NUPLAZID, UBRELVY, VYVGART HYTRULO, BOTOX.
Industry payments across MS — which companies pay providers there.
